Moderna Inc (MRNA)
Healthcare
Biotechnology
55.10 $
+0.6%
vs. previous close
Closing price · As of: 3. Aug 2026
Moderna Inc (MRNA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -526 million $. Tick rows to compare them in a chart.
| Tick rows to compare them in a chart (up to 4) | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1,600 | 622 | -989 | -1,274 | -1,566 | 825 | -1,037 | -919 | -847 | 951 | -630 | -526 | -1,052 | |
| 249 | 202 | 36 | 41 | 52 | 60 | 39 | 57 | 52 | 67 | 59 | 63 | 241 | |
| 77 | 79 | 101 | 112 | 112 | 104 | 115 | 130 | 125 | 113 | 104 | 120 | 462 | |
| 1,599 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 182 | 249 | 60 | -146 | 86 | 1,737 | -211 | -297 | -818 | 1,580 | 553 | -553 | 762 | |
| 140 | 220 | 196 | 182 | 151 | 522 | 127 | 3.0 | 33 | 39 | 62 | 37 | 171 | |
| 789 | -538 | 118 | 1,649 | 721 | -539 | 730 | 564 | 700 | -48 | -76 | 329 | 905 | |
| 59 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | |
| -65 | – | – | – | 3.0 | -14 | 2.0 | -5.0 | -3.0 | 566 | 0.0 | – | – | |
| -58 | -109 | 14 | 34 | 11 | -3.0 | 4.0 | 9.0 | -1.0 | 560 | 17 | 14 | 590 | |
| -869 | -25 | -857 | 409 | -833 | 282 | -303 | -345 | -147 | 1,462 | -688 | -185 | 442 | |
| -1,740 | 402 | -1,185 | -1,456 | -1,717 | 303 | -1,164 | -922 | -880 | 912 | -692 | -563 | -1,223 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.